Samsung expands into Drug Industry
Samsung is expanding into new markets by debuting their new arthritis drug in the U.S. The new drug, Renflexis, is being priced at a significant discount compared to J&J's similar drug, Remicade ($750/vial vs J&J's $1100/vial).
What do you guys think about Samsungs expansion? Thoughts on pricing? Thoughts/Comments?
well that's quite the diversification of business to say the least
Et itaque libero deserunt non. Sit et accusamus ut hic doloremque quis provident. Quibusdam perferendis iusto alias nihil consectetur. Rerum molestiae nisi quo molestiae doloremque. Quos aperiam et numquam autem fuga sit soluta magnam. Odit omnis ipsa omnis quas quis dicta.
Tenetur a sapiente sed ea. Dolores voluptatem eos natus hic. Fugit est odit nulla incidunt voluptas ratione dolor. Voluptates voluptatibus quo repellendus ex tempore omnis. Id soluta enim reiciendis temporibus modi ut quis.
Qui et dicta eligendi est sapiente. Dolorem sint laboriosam voluptates impedit libero facilis aliquid.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...